• Lead Drug FGL Found To Prevent Impaired Cognition
• R&D Update, Publication & Conference Presentation
• CHDI selects ENKAM’s compounds for preclinical tes
• Presentation at BIO-Europe
• Attendance at Conferences
• Participation at Conference
• The ENKAM approach shows potential in treatment of
• Discovery of Novel Compound Classes
• Positive Preclinical Data - Traumatic Brain Injury
• Appointment of Executive Chairman
• New Promising Treatment of Alzheimer’s Disease
• EU 6FP Grants EUR9.7 million to European Research
• Glossary

News

_________________________________________________________________

January 11, 2008

Lead Drug FGL Found To Prevent Impaired Cognition and Maintain Tissue Repair Mechanism After Chronic Stress

October 8, 2007

R&D Update, Key Scientific Publication & Presentation at BioPartnering Europe Conference, London

December 4, 2006

CHDI selects ENKAM’s compounds for preclinical testing in Huntington’s disease transgenic model

November 8, 2006

Presentation at BIO-Europe, Dusseldorf, Germany

October 13, 2006

Attendance at Conferences

September 26, 2006

Participation at Conference

September 11, 2006

The ENKAM approach shows potential in treatment of diabetes

July 10, 2006

Discovery of Novel Compound Classes

May 30, 2006

Positive Preclinical Data in Traumatic Brain Injury

March 20, 2006

Appointment of Executive Chairman

May 18, 2005

New Promising Treatment of Alzheimer's Disease

June 16, 2004

EU 6FP Grants EUR9.7 million to European Research in Alzheimer’s Disease